BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 9442893)

  • 21. BSE: can we predict the future?
    Plum J
    Verh K Acad Geneeskd Belg; 1997; 59(5):435-49. PubMed ID: 9490927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion diseases and the BSE crisis.
    Prusiner SB
    Science; 1997 Oct; 278(5336):245-51. PubMed ID: 9323196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMR structure of the mouse prion protein domain PrP(121-231).
    Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K
    Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the biology of prions.
    Prusiner SB; Gabizon R; McKinley MP
    Acta Neuropathol; 1987; 72(4):299-314. PubMed ID: 3554880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.
    Weissmann C; Fischer M; Raeber A; Büeler H; Sailer A; Shmerling D; Rülicke T; Brandner S; Aguzzi A
    Rev Sci Tech; 1998 Apr; 17(1):278-90. PubMed ID: 9638817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mechanisms of degeneration of the central nervous system--prion structure and biology.
    Prusiner SB; Stahl N; DeArmond SJ
    Ciba Found Symp; 1988; 135():239-60. PubMed ID: 2900720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prions mediated neurodegenerative disorders.
    Huang WJ; Chen WW; Zhang X
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4028-34. PubMed ID: 26592824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular biology and pathogenesis of prion diseases.
    Prusiner SB
    Trends Biochem Sci; 1996 Dec; 21(12):482-7. PubMed ID: 9009832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular biology and transgenetics of prion diseases.
    Prusiner SB
    Crit Rev Biochem Mol Biol; 1991; 26(5-6):397-438. PubMed ID: 1684745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormalities in stress proteins in prion diseases.
    Tatzelt J; Voellmy R; Welch WJ
    Cell Mol Neurobiol; 1998 Dec; 18(6):721-9. PubMed ID: 9876878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein.
    Vilette D; Andreoletti O; Archer F; Madelaine MF; Vilotte JL; Lehmann S; Laude H
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4055-9. PubMed ID: 11259656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prion protein self-interactions: a gateway to novel therapeutic strategies?
    Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
    Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prions in skeletal muscle.
    Bosque PJ; Ryou C; Telling G; Peretz D; Legname G; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3812-7. PubMed ID: 11904434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of prion diseases and prion diversity in mice.
    Carlson GA; DeArmond SJ; Torchia M; Westaway D; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):363-9. PubMed ID: 7913753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cloning and sequence analysis of prion protein gene in Xiji donkey in China.
    Zhang Z; Wang R; Xu L; Yuan F; Zhou X; Yang L; Yin X; Xu B; Zhao D
    Gene; 2013 Oct; 529(2):345-50. PubMed ID: 23954254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into prion strains and neurotoxicity.
    Aguzzi A; Heikenwalder M; Polymenidou M
    Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fundamentals of prions and their inactivation (review).
    Sakudo A; Ano Y; Onodera T; Nitta K; Shintani H; Ikuta K; Tanaka Y
    Int J Mol Med; 2011 Apr; 27(4):483-9. PubMed ID: 21271212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the natural variability of prion diseases.
    Geissen M; Krasemann S; Matschke J; Glatzel M
    Vaccine; 2007 Jul; 25(30):5631-6. PubMed ID: 17391814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.